...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Financials

Financials are posted.However whatever happened to the second tranche for 3 mill is still a mystery.I can only conclude that it did not take place.

Share
New Message
Please login to post a reply